This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.93% per year. These returns cover a period from January 1, 1988 through October 6, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
medical-devices: Archive
Best Momentum Stock to Buy for Nov. 19th
by Zacks Equity Research
TCMD, SWDBY and NPSNY made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on November 19, 2025.
TCMDPositive Net Change SWDBYNegative Net Change NPSNYNegative Net Change
consumer-discretionary finance medical-devices
4 Must-Buy Efficient Stocks to Strengthen Your Portfolio Returns
by Santanu Roy
CNQ stands out in a screen highlighting four stocks with efficiency ratios above industry averages and solid earnings surprise records.
CLSPositive Net Change CNQPositive Net Change TCMDPositive Net Change ARLOPositive Net Change
computers medical-devices oil-energy tech-stocks
Will Ion Platform's 52% Growth Make It ISRG's Next Growth Engine?
by Indrajit Bandyopadhyay
Intuitive Surgical's Ion platform represents robust growth potential with strong procedure growth. Clinical trial data demonstrate superiority in diagnostic yield.
JNJNegative Net Change MDTNegative Net Change ISRGPositive Net Change
medical medical-devices
BSX's Neuromodulation Prospect Looks Strong: What's Behind It?
by Moumi Mondal
Boston Scientific rides on strong neuromodulation momentum as sales climb, new technologies gain traction and recent acquisitions expand its pain-treatment reach.
ABTNegative Net Change BSXNegative Net Change MDTNegative Net Change
medical medical-devices
New Strong Buy Stocks for Nov. 19: TCMD, NPSNY, and More
by Zacks Equity Research
TCMD, NPSNY, SBFG, OPBK and SONY have been added to the Zacks Rank #1 (Strong Buy) List on November 19, 2025.
TCMDPositive Net Change NPSNYNegative Net Change SBFGPositive Net Change OPBKPositive Net Change SONYNegative Net Change
consumer-discretionary finance medical-devices
Hims & Hers Plunges 15.6% in 3 Months: Time to Hold the Stock or Sell?
by Debanjana Dey
HIMS faces rising regulatory strain, margin pressure and competition despite strong revenue momentum.
TDOCPositive Net Change AMWLPositive Net Change HIMSPositive Net Change
medical medical-devices
BFLY Stock Down Despite Launching Compass AI to Drive POCUS Programs
by Zacks Equity Research
Butterfly Network unveils Compass AI to streamline POCUS workflows, boosting documentation compliance and unlocking more revenue for health systems.
BSXNegative Net Change ISRGPositive Net Change MEDPNegative Net Change BFLYPositive Net Change
medical medical-devices
Medtronic's Q2 Earnings & Revenues Beat Estimates, Stock Climbs
by Zacks Equity Research
MDT posts Q2 earnings and revenue beat, powered by strong Cardiovascular growth and a raised 2026 outlook that lifts its shares.
BSXNegative Net Change MDTNegative Net Change PODDNegative Net Change MEDPNegative Net Change
earnings medical medical-devices
Should You Continue to Hold Hologic Stock Post Q4 Earnings?
by Moumi Mondal
HOLX's solid Q4 growth and a pending $18.3B buyout sharpen its focus as the company prepares to end its publicly traded chapter.
ABTNegative Net Change HOLXPositive Net Change QGENNegative Net Change
medical medical-devices
Ecolab Launches Integrated Cooling Platform to Support AI Data Centers
by Zacks Equity Research
ECL's new Cooling as a Service platform targets soaring AI data center demand with integrated site-to-chip efficiency upgrades.
BSXNegative Net Change ECLNegative Net Change ISRGPositive Net Change MEDPNegative Net Change
medical medical-devices
Do Options Traders Know Something About Insulet Stock We Don't?
by Zacks Equity Research
Investors need to pay close attention to PODD stock based on the movements in the options market lately.
PODDNegative Net Change
medical medical-devices
Best Momentum Stock to Buy for Nov. 17th
by Zacks Equity Research
ROKU, NRIM and ELMD made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on November 17, 2025.
ELMDPositive Net Change NRIMPositive Net Change ROKUNegative Net Change
consumer-discretionary finance medical-devices
MiMedx (MDXG) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
MDXGPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
4 Medical Product Stocks to Watch From a Challenging Industry
by Indrajit Bandyopadhyay
The Zacks Medical products industry sees steady demand, but macro headwinds keep growth under pressure in 2025. BSX, PODD, BLFS and ALUR reflect the favorable fundamentals.
BSXNegative Net Change BLFSPositive Net Change PODDNegative Net Change ALURPositive Net Change
medical-devices
CVS Health Posts Strong Q3 Earnings: How to Play the Stock Now?
by Moumi Mondal
CVS posts record Q3 revenues and a sharp EPS jump, lifting its 2025 outlook, while momentum builds across Aetna, Health Services and Pharmacy.
UNHPositive Net Change HUMPositive Net Change CVSNegative Net Change
medical medical-devices
Nexa Resources S.A. (NEXA)'s Technical Outlook is Bright After Key Golden Cross
by Zacks Equity Research
Should investors be excited or worried when a stock's 50-day simple moving average crosses above the 200-day simple moving average?
NEXAPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Twilio (TWLO) Now Trades Above Golden Cross: Time to Buy?
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
TWLONegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
FONAR Stock Gains Post Y/Y Decline in Q1 Earnings and Profit
by Zacks Equity Research
FONR reports top-line growth for first-quarter fiscal 2026 amid earnings decline and increased SG&A and operating expenses.
FONRPositive Net Change
earnings medical medical-devices
The Zacks Analyst Blog Highlights NVIDIA, Micron Technology and Thermo Fisher Scientific
by Zacks Equity Research
Zacks spotlights NVIDIA, Micron and Thermo Fisher in its latest Analyst Blog, highlighting AI-driven tailwinds, memory-market momentum and ongoing innovation across life sciences.
MUNegative Net Change NVDANegative Net Change TMOPositive Net Change
computers medical-devices semiconductor
HealthEquity Rolls Out Agentic AI to Elevate Member Support Experience
by Zacks Equity Research
HQY's new agentic AI is likely to provide faster, more intuitive support across channels, aiming to boost member satisfaction.
BSXNegative Net Change ISRGPositive Net Change HQYNegative Net Change MEDPNegative Net Change
medical medical-devices
Boston Scientific Up 7% in a Month: How Should You Play the Stock?
by Moumi Mondal
BSX's month-long rally, strong Q3 beats and expansion into chronic pain solutions sharpen investor focus.
ABTNegative Net Change BSXNegative Net Change BAXPositive Net Change
medical medical-devices
Top Research Reports for NVIDIA, Micron Technology & Thermo Fisher
by Mark Vickery
NVIDIA, Micron Technology and Thermo Fisher lead today's top analyst picks, each showing strong growth trends and strategic advances.
LMTPositive Net Change BMYPositive Net Change MUNegative Net Change NVDANegative Net Change TMOPositive Net Change UBERPositive Net Change
computers medical-devices semiconductor
BDX Unveils Portable PureWick System for On-the-Go Incontinence Care
by Zacks Equity Research
BD expands its PureWick line with a portable system built for discreet, mobile incontinence care, aiming to deepen its home-care reach.
BSXNegative Net Change BDXPositive Net Change HQYNegative Net Change SOLVNegative Net Change
medical medical-devices
STXS Secures FDA Approval for GenesisX to Broaden Surgical Robotics
by Zacks Equity Research
Stereotaxis wins FDA clearance for GenesisX, a streamlined robotic system aimed at boosting hospital adoption and accelerating growth.
BSXNegative Net Change STXSPositive Net Change HQYNegative Net Change SOLVNegative Net Change
medical medical-devices
Is Force Feedback the Next Big Catalyst for ISRG's da Vinci Sales?
by Indrajit Bandyopadhyay
Intuitive Surgical's new force-feedback upgrades for da Vinci 5 could spark its next adoption wave as early clinical evidence strengthens.
SYKNegative Net Change ISRGPositive Net Change GMEDNegative Net Change
medical medical-devices